Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Brainsway ( (BWAY) ).
On August 13, 2025, BrainsWay Ltd. reported a record quarterly revenue of $12.6 million for Q2 2025, marking a 26% increase from the previous year. The company also raised its full-year 2025 revenue and EBITDA guidance, reflecting strong business momentum and successful execution of its growth strategy. With a 35% increase in shipped Deep TMS systems and significant progress in strategic initiatives, including equity financing transactions and clinical trials, BrainsWay continues to strengthen its position in the mental health industry.
The most recent analyst rating on (BWAY) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Brainsway stock, see the BWAY Stock Forecast page.
Spark’s Take on BWAY Stock
According to Spark, TipRanks’ AI Analyst, BWAY is a Outperform.
Brainsway’s strong financial performance and positive earnings call guidance significantly contribute to its overall score. While the technical indicators show moderate bullish momentum, the high P/E ratio and absence of a dividend yield are valuation concerns.
To see Spark’s full report on BWAY stock, click here.
More about Brainsway
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, utilizing its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology. The company offers FDA-cleared treatments for major depressive disorder, obsessive-compulsive disorder, and smoking addiction, and is engaged in ongoing clinical trials for various psychiatric, neurological, and addiction disorders. Founded in 2003, BrainsWay operates in the United States and Israel, focusing on increasing global awareness and access to Deep TMS.
Average Trading Volume: 46,225
Technical Sentiment Signal: Buy
Current Market Cap: $230.6M
See more insights into BWAY stock on TipRanks’ Stock Analysis page.